| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1872-034X.2008.00338.X |
| P698 | PubMed publication ID | 18430093 |
| P2093 | author name string | Takafumi Ichida | |
| Masaharu Yoshikawa | |||
| Hironobu Nakamura | |||
| Naofumi Ono | |||
| Hiraku Yodono | |||
| P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases | Q33344056 | ||
| Hepatocellular carcinoma: current management and future trends. | Q35929180 | ||
| Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion | Q40339271 | ||
| P433 | issue | 5 | |
| P921 | main subject | cisplatin | Q412415 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 474-483 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Hepatology Research | Q15752035 |
| P1476 | title | Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma | |
| P478 | volume | 38 |
| Q33440349 | A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma |
| Q46355180 | A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis |
| Q84801061 | A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial |
| Q53615583 | A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma. |
| Q37232002 | A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma |
| Q36120874 | Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case |
| Q27004276 | Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers |
| Q41145089 | Antitumoral effect of Ocoxin in hepatocellular carcinoma. |
| Q92571935 | Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients |
| Q37708002 | Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age. |
| Q38639762 | Chemotherapy for hepatocellular carcinoma: The present and the future |
| Q47775953 | Chemotherapy for hepatocellular carcinoma: current status and future perspectives |
| Q44769237 | Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy |
| Q82742558 | Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma |
| Q53247409 | Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin). |
| Q46322363 | Comparison of the antitumor efficacy of transcatheter arterial chemoembolization with a miriplatin-iodized oil suspension and a cisplatin-iodized oil suspension for hepatocellular carcinoma |
| Q40729549 | Current chemotherapies for advanced hepatocellular carcinoma |
| Q38843057 | Current status and future prospects of chemotherapy for advanced hepatocellular carcinoma |
| Q38032906 | Current status of hepatocellular carcinoma treatment in Japan: hepatic arterial infusion chemotherapy |
| Q46821188 | DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway |
| Q41072005 | Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two cases |
| Q58806056 | Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma |
| Q53573051 | Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion. |
| Q86992619 | Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization |
| Q34390215 | Future perspectives on the treatment of hepatocellular carcinoma with cisplatin |
| Q53279945 | Hepatic Arterial Infusion Therapy with a Fine Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis |
| Q38161384 | Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in Japan |
| Q53161133 | Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weighting. |
| Q33418923 | Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II cli |
| Q38410821 | Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma |
| Q48088986 | Local control and prognostic significance of transarterial treatment for limited recurrence of ovarian cancer as third-line and beyond therapy |
| Q39863380 | Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. |
| Q37642185 | Newer treatments for advanced hepatocellular carcinoma |
| Q51095274 | Pharmacokinetics and Histopathological Findings of Chemoembolization Using Cisplatin Powder Mixed with Degradable Starch Microspheres in a Rabbit Liver Tumor Model. |
| Q35051975 | Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma |
| Q31096586 | Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma. |
| Q33428936 | Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil |
| Q83509966 | Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/II hepatocellular carcinoma |
| Q90727327 | Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial |
| Q84872084 | Short-term therapeutic effects of transcatheter arterial chemoembolization using miriplatin-lipiodol suspension for hepatocellular carcinoma |
| Q36230740 | Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study |
| Q37387978 | Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial |
| Q88310077 | Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial |
| Q39709255 | The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas. |
| Q38022245 | Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review). |
| Q33393492 | Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion |
| Q33573019 | Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial |
| Q39957932 | Transcatheter arterial infusion chemotherapy with cisplatin-lipiodol suspension in patients with hepatocellular carcinoma |
| Q33660203 | Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial. |
| Q57491231 | Treatment strategies for advanced hepatocellular carcinoma: Sorafenib hepatic arterial infusion chemotherapy |
| Q39879933 | Tunicamycin suppresses cisplatin-induced HepG2 cell apoptosis via enhancing p53 protein nuclear export |
| Q85048758 | Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma |
Search more.